SouthState’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
Other funds holding CRSP
SouthState's CRSP Position: Q3 2026 in Review
SouthState held its CRISPR Therapeutics (CRSP) position steady in Q3 2026 at 50 shares worth $2.77K. The position accounts for ﹤0.01% of the portfolio, ranked #909.
SouthState first reported a position in CRSP in Q2 2024 and has held it in 8 quarters since. The position peaked at $6.75K in Q2 2024. 422 funds tracked by Wall St. Rank hold CRSP as of Q3 2026.
- SouthState held 50 shares of CRISPR Therapeutics worth $2.77K as of Q3 2026.
- SouthState left its CRISPR Therapeutics share count unchanged in Q3 2026.
- CRISPR Therapeutics made up ﹤0.01% of SouthState's portfolio in Q3 2026, its #909 holding.
- SouthState first reported a position in CRISPR Therapeutics in Q2 2024 and has held it in 8 quarters since.
- SouthState's CRISPR Therapeutics position peaked at $6.75K in Q2 2024.
- 422 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q3 2026.
Based on SouthState's 13F filing for Q3 2026, filed 9 Nov 2026.